By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Japan Tobacco, Inc. 

2-2-1 Toranomon

Minato-ku  Tokyo  105-8422  Japan
Phone: 81-3-3582-3111 Fax: 81-3-5572-1441


SEARCH JOBS








Company News
Keryx Biopharmaceuticals (KERX) Announces Positive Top-Line Results from Phase 3 Study of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco, Inc. and Torii Pharmaceutical Co. 4/23/2012 10:40:56 AM
Merck & Co., Inc. (MRK) Ditches Bone Drug Deal with Japan Tobacco, Inc. 10/17/2011 8:36:16 AM
Keryx Biopharmaceuticals (KERX) Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex(TM)) in Japan by Partner, Japan Tobacco, Inc. and Torii Pharmaceutical Co. 4/18/2011 7:00:20 AM
Japan Tobacco's Novel Osteoporosis Drug Promising in Early Study 9/17/2009 11:17:03 AM
Orphagen Pharmaceuticals Announces Collaboration And License Agreement With Japan Tobacco 1/7/2009 11:13:09 AM
Merck & Co., Inc. (MRK) (JOBS), Japan Tobacco in Osteoporosis Drug Deal 9/25/2008 6:42:47 AM
Keryx Biopharmaceuticals (KERX) Licenses Rights to Japan Tobacco; Torii Pharmaceutical Co. to Pay up to $100 Million 9/26/2007 6:38:51 AM
Arcadia Biosciences, Inc. Licenses Corn And Rice Transformation Technology From Japan Tobacco 10/4/2006 11:44:53 AM
Japan Tobacco And GlaxoSmithKline (GSK) Conclude Licensing Agreement For New Drug Candidate 4/20/2006 11:04:07 AM
Two New Anti-HIV Drugs Launched By Japan Tobacco And Torii Pharmaceutical Co.10/19/2005 5:13:14 PM
12
//-->